What determines the cash price of oral Wegovy, including pharmacy and delivery fees?

Wegovy is an injectable, not an oral medication. Its cash price is determined by the manufacturer's list price, pharmacy fees, and any available savings programs.

Wegovy Is Not an Oral Medication

A common point of confusion is whether Wegovy is available as a pill. Wegovy (semaglutide) is exclusively an injectable medication, administered once-weekly via a pre-filled pen. It is FDA-approved for chronic weight management in adults and adolescents.

The active ingredient in Wegovy, semaglutide, is available in an oral form called Rybelsus. However, Rybelsus is a different medication with a different dosing schedule and is FDA-approved only for managing blood sugar in adults with type 2 diabetes, not for weight loss.

Therefore, there is no such thing as 'oral Wegovy.' Any discussion of the cash price of Wegovy refers to the once-weekly injectable pens. Understanding this distinction is crucial when exploring treatment options with a physician.

Manufacturer's List Price

The primary factor determining the cash price of Wegovy is its Wholesale Acquisition Cost (WAC), or list price, set by the manufacturer, Novo Nordisk. As of early 2024, the list price for a 28-day supply of Wegovy (one box containing four pens) is approximately $1,349.02.

This price is for the medication itself, before any pharmacy markups, dispensing fees, or insurance coverage is applied. The WAC is the price wholesalers pay to the manufacturer, and it serves as the baseline for the entire pricing structure that follows.

The list price is the same for all dose strengths, from the initial 0.25 mg starting dose to the 2.4 mg maintenance dose. Patients paying cash can therefore expect the baseline cost to remain consistent throughout their treatment titration schedule.

Pharmacy Markup and Dispensing Fees

Pharmacies do not sell medications at the WAC. They add a markup to cover their operational costs and generate a profit. This markup percentage can vary significantly from one pharmacy to another, including large retail chains, independent pharmacies, and mail-order services.

In addition to a markup, pharmacies charge a dispensing fee for the professional service of filling the prescription. This fee also varies but contributes to the final price you pay at the counter. These costs are why the cash price for Wegovy can differ between pharmacies like CVS, Walgreens, or your local independent pharmacy.

When paying cash, it is often worthwhile to contact multiple licensed U.S. pharmacies to compare their final prices for a 28-day supply. Some may offer more competitive pricing than others, though the final cost will still be substantial.

Savings Programs and Patient Assistance

Novo Nordisk offers a savings program for Wegovy to help reduce out-of-pocket costs for commercially insured patients. For those paying cash or whose insurance does not cover Wegovy, this card may offer savings of up to $500 per 28-day supply.

However, even with the maximum savings of $500, the final cash price remains high, often exceeding $850 per month. This program is not available to patients with government-funded insurance like Medicare or Medicaid.

Novo Nordisk also has a Patient Assistance Program (PAP) that may provide Wegovy at no cost to qualifying individuals. The PAP has strict eligibility requirements, including being a U.S. citizen or legal resident, having no prescription insurance, and meeting specific household income thresholds.

How Telehealth Programs Factor In

Physician-supervised telehealth practices like GOAL.MD can help patients navigate the process of obtaining brand-name GLP-1s. A program fee typically covers the physician consultation, medical evaluation, and ongoing support for your physician-led weight loss plan.

These services often include managing the prescription and assisting with insurance prior authorizations, which can be complex. However, the cost of the Wegovy medication itself is separate from the telehealth program fee and is paid directly to the pharmacy filling the prescription.

A comprehensive program provides the necessary medical supervision and administrative support to safely use medications like Wegovy, but patients paying cash for the drug must still budget for the high cost at the pharmacy. Our team helps you explore all avenues for access as part of your overall [weight loss](/weight-loss) journey.

Bottom Line

Wegovy is a once-weekly injectable medication, and no oral version is approved for weight loss. Its high cash price is primarily driven by the manufacturer's list price of over $1,300 per month, with additional costs from pharmacy fees.

While a manufacturer savings card can reduce the cash price by up to $500, the monthly cost remains a significant financial barrier for most patients without insurance coverage. A physician-supervised program can provide guidance, but does not directly alter the pharmacy's cash price for the medication.

This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for any health concerns or before starting a new treatment.

Drafted by the GOAL.MD Authority Engine and approved editorially by GOAL.MD staff. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.